Connections >> December 2014
Latest MSFHR News
- Trainee competition guidelines posted
- Nominations open for 2015 Aubrey J. Tingle Prize
- BC Cancer Agency study maps evolution of breast cancer
- UBC team to evaluate accelerated integrated primary and community care
- BC research informs global HPV vaccine guidelines
- Forum will foster digital health research collaboration
Happy holidays from MSFHR!
As 2014 draws to a close, we at MSFHR are pleased to reflect on an exciting and productive year. Over the past 12 months, we have made great progress working with our partners and other stakeholders to strengthen BC's capacity for world-class health research.
To illustrate our progress across a broad range of activities, we have prepared an interactive timeline of 2014 highlights.
Trainee competition guidelines posted
Application guidelines are now available for MSFHR's 2015 Research Trainee Program Competition for Post-Doctoral Fellowship Awards.
This funding competition is open to applicants who are eligible to hold a post-doctoral fellow position at a BC-based host institution for the duration of the Research Trainee Program – Post-Doctoral Fellowship Award. Host institutions must have a signed memorandum of understanding with MSFHR.
Note: The MSFHR ApplyNet system will open in early February 2015 to accept applications to this competition. Full application instructions will be posted at this time.
Letters of intent must be submitted by March 17, 2015. The deadline for receipt of full applications is April 20, 2015.
Nominations open for 2015 Aubrey J. Tingle Prize
Nominations are now being accepted for the sixth annual Aubrey J. Tingle Prize.
Named in honour of MSFHR's founding president & CEO, this prize is given to a British Columbia clinician scientist or scholar practitioner whose work in health research is internationally recognized and has significant impact on advancing clinical or health services and policy research.
MSFHR is proud to present the 2015 Aubrey J. Tingle Prize in partnership with LifeSciences BC for the first time in the award's history. The prize will be presented April 16, 2015, as part of the 17th annual LifeSciences BC Awards.
The deadline for nominations is Saturday, January 31, 2015.
BC Cancer Agency study maps evolution of breast cancer
A new study led by BC Cancer Agency scientists Dr. Samuel Aparicio and Dr. Sohrab Shah represents a significant advance in our understanding of how complex cancers, such as breast cancer, evolve over time.
The study, published this month in the journal Nature, uses genomic sequencing in combination with a new computational model called PyClone to track which cells and mutations dominate as a cancer evolves.
PyClone was developed by Shah, whose work is supported by a 2011 MSFHR Scholar Award. Aparicio is the recently named winner of the 2014 Aubrey J. Tingle Prize.
UBC team to evaluate accelerated integrated primary and community care
A research team from UBC's Centre for Health Services and Policy Research has been selected to evaluate the impact of the BC Ministry of Health's Accelerated Integrated Primary and Community Care (aIPCC) initiatives.
The researchers, led by Dr. Kim McGrail, will use Ministry of Health data to identify patterns of health services use, such as emergency department visits, acute care admissions, and long-term residential care admissions. Their study will determine how these patterns have changed as a result of aIPCC initiatives, which are being implemented across the province to support the ministry's goal of providing as many health services as possible in the community.
McGrail and her team were selected to undertake this project through a competitive request for applications issued by MSFHR in August.
BC research informs global HPV vaccine guidelines
MSFHR-supported research underpins a key policy document for controlling cervical cancer issued December 3 by the World Health Organization (WHO).
The new WHO guidelines recommend vaccinating 9- to 13-year-old girls with two doses of human papillomavirus (HPV) vaccine, instead of the standard three-dose regimen. Two doses have been found to be just as effective as three at conferring immunity to HPV infection, based on a growing body of research evidence that includes MSFHR-funded studies by researchers at the Child & Family Research Institute and the BC Centre for Disease Control.
A new study by the MSFHR-funded research team seeks to determine if a two-dose vaccine provides equivalent long-term protection over a 10-year period.
Forum will foster digital health research collaboration
On February 5, 2015, MSFHR will co-host a one-day interactive forum focused on how collaboration between research, industry, government, health care, and education sectors can lead to digital health solutions to some of health care's most pressing challenges.
Engagement sessions will create opportunities for all sectors to jointly explore innovative solutions for youths between 11 and 25 years old with mental health conditions and seniors living at home with complex care needs.
The forum will also support the formation of cross-sectoral research teams in preparation for CIHR's eHealth Innovations Partnership Program (eHIPP) funding opportunity.